BioSpace News Archive

OrphoMed, Inc., a clinical-stage biopharmaceutical company developing first-in-class dimer therapeutics, today announced positive results from the recent Phase 2 study of ORP-101 for treatment of irritable bowel syndrome with diarrhea (IBS-D).

Viveve Medical, Inc., a medical technology company focused on women’s health, announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright BIOCONNECT Conference, January 10 - 13, 2022.

DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 40th annual J.P. Morgan Healthcare Conference on January 10, 2022.

Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, announced a partnership with Illumina, Inc., aimed at assessing the real-world uptake and actionability of comprehensive genomic profiling in the community oncology health system setting.

Genmab A/S (Nasdaq: GMAB) and Synaffix B.V., announced today that Genmab and Synaffix have signed a license agreement providing Genmab broad access to Synaffix’s ADC technologies.

Privia Health Group, Inc. (Nasdaq: PRVA) announced that it will participate in the 40th Annual J.P. Morgan Healthcare Conference.

Boston Scientific Corporation (NYSE: BSX) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022.

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), today announced that the empty capsule material that makes up PharmaCyte’s CypCaps® pancreatic cancer product candidate is not toxic for the encapsulated cells inside the CypCaps.

ModivCare Inc. today announced that Dan Greenleaf, President and Chief Executive Officer, and Heath Sampson, Chief Financial Officer, are scheduled to present at the following upcoming investor conference.

Apollo Medical Holdings, Inc. today announced that Brandon Sim , Co-Chief Executive Officer, is scheduled to present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 10:30 a.m. PT/1:30 p.m. ET.